Tag: Vertex Pharmaceuticals Inc
Bluebird Bio gene therapy sells itself to Carlyle and SK Capital
Sopa Images | Lightrocket | Getty ImagesBluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the compan [...]
Sickle cell gene therapies push health plans toward new payment models
Starting in his early teens, Deshawn "DJ" Chow wasn't sure he'd ever be able to live a normal life. Crushing pain episodes brought on by his sickle ce [...]
FDA approves Vertex non-opioid painkiller drug Journavx
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder | ReutersThe Food and Drug Administration on Thursday [...]
Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues
The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmin [...]
Vertex non-opioid painkiller shows positive late-stage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019.Brian Snyder | ReutersVertex Pharmaceuticals on T [...]
Vertex non-opioid painkiller posts positive mid-stage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. Brian Snyder | ReutersShar [...]
First CRISPR gene-editing treatment approved in U.S.
Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test.Md Babul Hosen | Istock | Getty ImagesThe [...]
U.S. poised to approve breakthrough treatment
At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more t [...]
Walgreens, Coinbase, Duolingo, Ralph Lauren
A Walgreens store is seen on August 07, 2019 in Miami, Florida.Joe Raedle | Getty ImagesCheck out the companies making headlines in midday trading.Dox [...]
Cramer’s lightning round: Stay with Vertex Pharmaceuticals
Getty Images Holdings Inc: "I think down here at $4, I'm not a SPAC guy, okay, but this one may be actually worth looking at."Jim Cramer's Guide to In [...]
Jim Cramer says investors should eye these three tech names in the Nasdaq 100
CNBC's Jim Cramer on Tuesday told investors his three stock picks from the worst- and best-performing stocks in the Nasdaq 100 during the first half o [...]
I’m sticking with Marvell Technology
Rocket Companies Inc: "I said the Fed was raising rates: you can't own anything in that area. And the Fed is still raising, so you still can't."Marvel [...]
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
Investors should consider purchasing stock of the first quarter's biggest losers if the market shows signs of recovering on its own, CNBC's Jim Cramer [...]
Stem cells may finally offer a cure for Type 1 diabetes
There are 537 million people around the world living with diabetes. And that number is growing. When people have Type 1 diabetes, the immune system at [...]
30-year-old female founder’s billion-dollar bet on CRISPR gene editing
Janice Chen (C) and her Mammoth Biosciences co-founders Trevor Martin (L) and Lucas Harrington (R). CRISPR gene editing pioneer and Nobel Prize winner [...]